Affymetrix's Q4 Revenues Rise 10 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market Wednesday that its fourth quarter revenues climbed around 10 percent year over year, as sales growth for its consumables products and eBioscience business more than offset a decline in instrument revenue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.